Trehalose Neuroprotective Effects on the Substantia Nigra Dopaminergic Cells by Activating Autophagy and Non-canonical Nrf2 Pathways

Document Type : Research article


1 Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.

2 Department of Clinical Biochemistry, Faculty of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran.

3 Hearing Disorders Research Center, Loghman Hakim Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

4 Department of Anatomical Sciences and Biology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

5 Department of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.


Trehalose, as a natural disaccharide, is known as an autophagy inducer. The neuroprotective
effects of trehalose in the rat model of Parkinson′s disease were the aim of the present study.
Parkinson′s disease model was induced by injecting 6-hydroxydopamine (6-OHDA) in the
striatum of male Wistar rats. Apomorphine-induced behavior and substantia nigra neuronal
counts were applied to evaluate the neuroprotective effects of trehalose. The autophagy was
studied using the expression of p62 and LC3II/LC3I ratio. In addition, the antioxidant effects
of trehalose were assessed by analyzing the levels of nuclear factor (erythroid-derived 2)-like
2 (Nrf2) and also glutathione reductase (GR), glutathione peroxidase (GPx) and Catalase
(CAT) enzymes. Moreover, the levels of 3, 4-dihydroxyphenylacetic acid (DOPAC) and
dopamine (DA) were assessed.The behavioral test showed that trehalose in the treatment group
reduced the damage to the substantial nigra dopaminergic neurons, which was characterized
by improved motor and reduced rotations in the treatment group as compared with the lesion
group. In the histological examinations of the treatment group, trehalose prevented the
destruction of dopaminergic neurons. Trehalose treatments increased autophagy (high LC3II/
LC3I ratio) and the expression of the p62 protein as well. Through p62-dependent manner,
it led to increased nuclear translocation of Nrf2 transcription factor and elevated expression
of downstream antioxidant enzymes, such as GR, GPx, and CAT, restoring DA and DOPAC
contents of the cells. In the current study, trehalose simultaneously protects substantia nigra
dopaminergic cells by activating both non-canonical p62/SQSTM1-Keap1-Nrf2 and autophagy


Main Subjects

Leslie SB, Israeli E, Lighthart B, Crowe JH and Crowe
LM. Trehalose and sucrose protect both membranes
and proteins in intact bacteria during drying. Appl.
Environ. Microbiol. (1995) 61: 3592-7.
Yang JL, Mu H, Lu ZR, Yin SJ, Si YX, Zhou SM,
Zhang F, Hu WJ, Meng FG, Zhou HM, Zhang ZP and
Qian GY. Trehalose has a protective effect on human
brain-type creatine kinase during thermal denaturation.
Appl. Biochem. Biotechnol. (2011) 165: 476-84.
Sarkar S, Davies JE, Huang Z, Tunnacliffe A and
Rubinsztein DC. Trehalose, a novel mTORindependent autophagy enhancer, accelerates the
clearance of mutant huntingtin and alpha-synuclein. J.
Biol. Chem. (2007) 282: 5641-52.
Du J, Liang Y, Xu F, Sun B and Wang Z. Trehalose
rescues Alzheimer′s disease phenotypes in APP/PS1
transgenic mice. J. Pharm. Pharmacol. (2013) 65:
Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, Doi
H, Kurosawa M, Nekooki M and Nukina N. Trehalose
alleviates polyglutamine-mediated pathology in a
mouse model of Huntington disease. Nat. Med. (2004)
10: 148-54.
He Q, Koprich JB, Wang Y, Yu WB, Xiao BG, Brotchie
JM and Wang J. Treatment with trehalose prevents
behavioral and neurochemical deficits produced in an
AAV alpha-synuclein rat model of parkinson′s disease.
Mol. Neurobiol. (2016) 53: 2258-68.
Dagda RK, Zhu J, Kulich SM and Chu CT.
Mitochondrially localized ERK2 regulates mitophagy
and autophagic cell stress: implications for Parkinson′s
disease. Autophagy (2008) 4: 770-82.
Darabi S, Tiraihi T, Delshad A, Sadeghizadeh M,
Khalil W and Taheri T. In-vitro non-viral murine proneurotrophin 3 gene transfer into rat bone marrow
stromal cells. J. Neurol. Sci. (2017) 375: 137-45.
Burks S, Raymick J, Robinson B, Hanig J and Sarkar
S. Neuroprotective effects of acetyl-l-carnitine (ALC)
in a chronic MPTP-induced Parkinson′s disease mouse
model: Endothelial and microglial effects. Neurosci.
Lett. (2019) 703: 86-95.
Sarkar S, Chigurupati S, Raymick J, Mann D, Bowyer
JF, Schmitt T, Beger RD, Hanig JP, Schmued LC and
Paule MG. Neuroprotective effect of the chemical
chaperone, trehalose in a chronic MPTP-induced
Parkinson′s disease mouse model. Neurotoxicology
(2014) 44: 250-62.
Mohandas J, Marshall JJ, Duggin GG, Horvath JS and
Tiller DJ. Differential distribution of glutathione and
glutathione-related enzymes in rabbit kidney. Possible
implications in analgesic nephropathy. Biochem.
Pharmacol. (1984) 33: 1801-7.
Henry V, Paille V, Lelan F, Brachet P and Damier P.
Kinetics of microglial activation and degeneration
of dopamine-containing neurons in a rat model of
Parkinson disease induced by 6-hydroxydopamine. J.
Neuropathol. Exp. Neurol. (2009) 68: 1092–102.
Abbaszadeh HA, Tiraihi T, Delshad A, Saghedizadeh
M, Taheri T, Kazemi H and Hassoun HK.
Differentiation of neurosphere-derived rat neural stem
cells into oligodendrocyte-like cells by repressing
PDGF-α and Olig2 with triiodothyronine. Tissue Cell
(2014) 46: 462-9.
Ghasemi Z, Naderi N, Shojaei A, Raoufy MR,
Ahmadirad N and Mirnajafi-Zadeh J. Effect of lowfrequency electrical stimulation on the high-K(+)-
induced neuronal hyperexcitability in rat hippocampal
slices. Neuroscience (2018) 369: 87-96.
Aboutorabi A, Naderi N, Gholami Pourbadie H,
Zolfagharian H and Vatanpour H. The effects of buthotus
schach scorpion venom on electrophysiological
properties of magnocellular neurons of rat supraoptic
nucleus. Iran. J. Pharm. Res. (2018) 17: 184-92.
Hosseini SM, Gholami Pourbadie H, Sayyah M,
Zibaii MI and Naderi N. Neuroprotective effect
of monophosphoryl lipid A, a detoxified lipid A
derivative, in photothrombotic model of unilateral
selective hippocampal ischemia in rat. Behav. Brain
Res. (2018) 347: 26-36.
Hosseini SM, Gholami Pourbadie H, Naderi N,
Sayyah M and Zibaii MI. Photothrombotically induced
unilateral selective hippocampal ischemia in rat. J.
Pharmacol. Toxicol. Methods (2018) 94: 77-86.
Asaadi S, Jahanbakhshi M, Lotfinia M and Naderi N.
The role of BK channels in antiseizure action of the
CB1 receptor agonist ACEA in maximal electroshock
and pentylenetetrazole models of seizure in mice. Iran.
J. Pharm. Res. (2017) 16: 640-7.
Farzanehfar V, Faizi M, Naderi N and Kobarfard
F. development of an analytical method for dibutyl
phthalate determination using surrogate analyte
approach. Iran. J. Pharm. Res. (2017) 16: 140-5.
Khodayar MJ, Shafaghi B, Naderi N and Zarrindast
MR. Antinociceptive effect of spinally administered
cannabinergic and 2-adrenoceptor drugs on the formalin
test in rat: possible interactions. J. Psychopharmacol.
(2006) 20: 67-74.
Haghparast A, Naderi N, Khani A, Lashgari R and
Motamedi F. Formalin-induced differential activation
of nucleus cuneiformis neurons in the rat: an
electrophysiological study. J. Pain (2010) 11: 32-43.
Razmi A, Zarghi A, Arfaee S, Naderi N and Faizi M.
evaluation of anti-nociceptive and anti-inflammatory
activities of novel chalcone derivatives. Iran. J.
Pharm. Res. (2013) 12: 153-9.
 Darabi Sh et al. / IJPR (2019), 18 (3): 1419-1428
Naderi N, Shafieirad E, Lakpoor D, Rahimi A
and Mousavi Z. Interaction between cannabinoid
compounds and capsazepine in protection against
acute pentylenetetrazole-induced seizure in mice. Iran.
J. Pharm. Res. (2015) 14: 115-20.
Sedaghat R, Roghani M and Khalili M. Neuroprotective
effect of thymoquinone, the nigella sativa bioactive
compound, in 6-hydroxydopamine-induced hemiparkinsonian rat model. Iran. J. Pharm. Res. (2014)
13: 227-34.
Mignon LJ and Wolf WA. 8-hydroxy-2-(di-npropylamino)tetralin reduces striatal glutamate in an
animal model of Parkinson′s disease. Neuroreport
(2005) 16: 699-703.
Roghani M and Behzadi G. Neuroprotective effect of
vitamin E on the early model of Parkinson′s disease in
rat: behavioral and histochemical evidence. Brain Res.
(2001) 892: 211-7.
Rezaei M, Nasri S, Roughani M, Niknami Z and Ziai
SA. Peganum harmala L. extract reduces oxidative
stress and improves symptoms in 6-hydroxydopamineinduced parkinson′s disease in rats. Iran. J. Pharm.
Res. (2016) 15: 275-81.
Negahdar F, Mehdizadeh M, Joghataei MT, Roghani
M, Mehraeen F and Poorghayoomi E. Berberine
chloride pretreatment exhibits neuroprotective effect
against 6-hydroxydopamine-induced neuronal insult in
rat. Iran. J. Pharm. Res. (2015) 14: 1145-52.
Eyhani-Rad S, Mohajjel Nayebi A, Mahmoudi J, Samini
M and Babapour V. Role of 5-hydroxytryptamine 1A
receptors in 6-hydroxydopmaine-induced catalepsylike immobilization in rats: a therapeutic approach
for treating catalepsy of parkinson′s disease. Iran. J.
Pharm. Res. (2012) 11: 1175-81.
Kumar R, Agarwal AK and Seth PK. Free radicalgenerated neurotoxicity of 6-hydroxydopamine. J.
Neurochem. (1995) 64: 1703-7.
Jing X, Wei X, Ren M, Wang L, Zhang X and
Lou H. Neuroprotective effects of tanshinone I
against 6-OHDA-induced oxidative stress in cellular
and mouse model of Parkinson’s disease through
upregulating Nrf2. Neurochem. Res. (2016) 41: 779-
Katsuragi Y, Ichimura Y and Komatsu M. Regulation
of the Keap1–Nrf2 pathway by p62/SQSTM1. Curr.
Opin. Toxicol. (2016) 1: 54-61.
Komatsu M, Kurokawa H, Waguri S, Taguchi K,
Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto
A and Tong KI. The selective autophagy substrate p62
activates the stress responsive transcription factor Nrf2
through inactivation of Keap1. Nat. Cell Biol. (2010)
12: 213.
Darabi S, Tiraihi T, Delshad A, Sadeghizadeh M,
Taheri T and Hassoun HK. Creatine enhances
transdifferentiation of bone marrow stromal cellderived neural stem cell into GABAergic neuron-like
cells characterized with differential gene expression.
Mol Neurobiol. (2017) 54: 1978-91.
Tian Y, Chang JC, Greengard P and Flajolet M.
The convergence of endosomal and autophagosomal
pathways: implications for APP-CTF degradation.
Autophagy (2014) 10: 694-6.
Aliaghaei A, Meymand AZ, Boroujeni ME, Khodagoli
F, Meftahi GH, Hadipour MM, Abdollahifar MA,
Mesgar S, Ahmadi H, Danyali S, Hasani S and Sadeghi
Y. Neuro-restorative effect of sertoli cell transplants in
a rat model of amyloid beta toxicity. Behav. Brain Res.
(2019) 367: 158-65.
Inami Y, Waguri S, Sakamoto A, Kouno T, Nakada K,
Hino O, Watanabe S, Ando J, Iwadate M, Yamamoto
M, Lee MS, Tanaka K and Komatsu M. Persistent
activation of Nrf2 through p62 in hepatocellular
carcinoma cells. J. Cell Biol. (2011) 193: 275-84.
Jain A, Lamark T, Sjøttem E, Larsen KB, Awuh JA,
Øvervatn A, McMahon M, Hayes JD and Johansen
T. p62/SQSTM1 is a target gene for transcription
factor NRF2 and creates a positive feedback loop by
inducing antioxidant response element-driven gene
transcription. J. Biol. Chem. (2010) 285: 22576-91.
Niknazar S, Nahavandi A, Peyvandi AA, Peyvandi H,
Roozbahany NA and Abbaszadeh HA. Hippocampal
NR3C1 DNA methylation can mediate part of
preconception paternal stress effects in rat offspring.
Behav. Brain Res. (2017) 324: 71-6.
Darabi S, Tiraihi T, Noori-Zadeh A, Rajaei F, Darabi L
and Abbaszadeh HA. Creatine and retinoic acid effects
on the induction of autophagy and differentiation of
adipose tissue-derived stem cells into GABAergic-like
neurons. J. Babol Univ. Med. Sci. (2017) 19: 41-9.
Ichimura Y, Waguri S, Sou YS, Kageyama S, Hasegawa
J, Ishimura R, Saito T, Yang Y, Kouno T, Fukutomi T,
Hoshii T, Hirao A, Takagi K, Mizushima T, Motohashi
H, Lee MS, Yoshimori T, Tanaka K, Yamamoto M
and Komatsu M. Phosphorylation of p62 activates the
Keap1-Nrf2 pathway during selective autophagy. Mol.
Cell. (2013) 51: 618-31.
Sanchez-Danes A, Benzoni P, Memo M, Dell′Era P,
Raya A and Consiglio A. Induced pluripotent stem
cell-based studies of Parkinson′s disease: challenges
and promises. CNS Neurol. Disord. Drug Targets
(2013) 12: 1114-27.
Kazemi H, Noori-Zadeh A, Darabi S and Rajaei F.
Lithium prevents cell apoptosis through autophagy
induction. Bratisl. Med. J. (2018) 119: 234-9.